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The results of 206 programmed ventricular stimu- 
iation studies performed in 130 patients (100 men 
and3Owomen,meanage62*12years,fstan- 
dad &viation) were examined prospectivety to de- 
terminetbewqueiaeof nonwstainedpdymorphi 
ventrichr tachycardia (VT) induced during pro- 
grammed ventricular stimulation. The clinical indi- 
cation for the eiecbpbydoiogic study was either 
documentedmonomorphic VT or unexpiained syn- 
cope. The pacing protocoi included 2 tight vehicu- 
iar pacing sites, 2 basic drive cycle lengths and up 
to 3 extrastimuli. In 111 studies, nonsudained 
po&nmpbic VT was induced and with continuation 
of the programmed stimulation protocot, sustained 
monomorphic VT was induced in 48 studies (43%) 
and polymorphic VT was induced in 13 studies 
(12%). Overall, sustained monomorphic VT w? in- 
ducedinl10studiesandsustainedpdymorphlc 
VT in 1% studies. The incidence of nonsustained 
polymorphicVTprecedingtheinductionofsus- 
tained polymorphii VT was signifkanUy greater 
than the inddence of nonsudained polymorpMc r 
preeedinzrtheinhctionofsustained~ 
VT (72 vs 44%, p <O.OS). Nonsustained polymor- 
phicVTisnotausefulpredktoroftheoutcomeof 
programmed ventkular stimulation. The use of 
nonwdaiwdpdymorphiivTarranendpointfor 
stimuiation wouid be likely to improve the specifk- 
ity of programmed ventricular stimulation by Iimit- 
ing the induction of sustained nonclinical arrhyth- 
miasthatreqhzcou -k,butattbecostof 
dgnificantly impairing the yield of monomorphic 
VT. 
(AmJCardid 1989;64:1148-1151) 
From the Division of Cardiology, Department of Internal Medicine, 
University of Michigan Medical Center, and the Section of Cardiology, 
Ann Arbor Veterans Administration Medical Center, Ann Arbor, 
Michigan. Manuscript received February 24,1989; revised manuscript 
received July 3, 1989, and accepted July 27. 
Address for reprints: William H. Kou, MD, Section of Cardiology 
(11 lA), Ann Arbor Veterans Administration Medical Center, 2215 
Fuller Road, Ann Arbor, Michigan 48 105. 
1148 THE AMERICAN JOURNAL OF CARDIOLOGY VOLUME 64 
I n patients who do not have a history of ventricular fibrillation or cardiac arrest, polymorphic ventricu- lar tachycardia (VT) or ventricular fibrillation in- 
duced by programmed ventricular stimulation may of- 
ten be laboratory artifacts that do not have clinical sig- 
nificance.1-3 Direct current countershock is needed to 
terminate these arrhythmias if they are sustained, and 
therefore it is desirable to avoid their induction. Limit- 
ing the number of extrastimuli to 2 would significantly 
reduce the incidence of nonclinical arrhythmias dur- 
ing programmed ventricular stimulation; however, thii 
would have the undesirable effect of also reducing the 
yield of clinically important VT.4-6 
We have observed that the induction of sustained 
polymorphic VT and ventricular fibrillation during pro- 
grammed ventricular stimulation is often preceded by 
the induction of nonsustained polymorphic VT. There- 
fore, it might be possible to avoid the induction of sus- 
tained polymorphic VT or ventricular fibrillation by 
moving to the next step in the stimulation protocol once 
nonsustained polymorphic VT is induced. However, it is 
unclear whether this practice would also limit the induc- 
tion of clinical forms of VT. Therefore, the present pro- 
spective study was designed to determine the eventual 
outcome of programmed ventricular stimulation once 
nonsustained polymorphic VT is induced, and how often 
the induction of clinical VT and sustained nonclinical 
forms of VT/ventricular fibrillation is preceded by the 
induction of nonsustained polymorphic VT. 
METNOD 
Charackistics of subjactsr Table I lists the clinical 
characteristics of the subjects in this prospective study. 
There were 130 patients (100 men and 30 women) with 
a mean age of 62 f 12 years (h standard deviation). 
These patients underwent electrophysiologic testing be- 
cause of a history of either documented monomorphic 
VT or unexplained syncope. Because of the uncertain 
significance of sustained polymorphic VT and ventric- 
ular fibrillation initiated by programmed ventricular 
stimulation in patients without a history of cardiac ar- 
rest or spontaneous ventricular fibrillation, patients tm- 
dergoing an electrophysiologic study for either of these 
2 indications were not included in the present study. In 
76 patients, the left ventricular ejection fraction was de- 
termined either by multigated radionuclide or contrast 
ventriculography. 
An&vhythmie thetrapy: One hundred fourteen 
studies were performed in the control state after all an- 
tiarrhythmics had been withheld for at least 5 half-lives. 
The remaining 92 studies were performed while patients 
were being treated with antiarrhythmic medications, af- 
ter induction of sustained monomorphic VT in a control 
study. Drug studies with type I antiarrhythmic medica- 
tions were performed after the patient had received 15 
doses of the agent. Drug studies with amiodarone were 
performed after a loading dose of 1,200 mg/day for 2 
WC&S. 
Programmed ventricular stimulation study: Electro- 
physiologic studies were performed in the postabsorp- 
tive, nonsedated state after informed consent was ob- 
tained. Two 6Fr quadripolar electrode catheters were 
inserted percutaneously into a femoral vein and posi- 
tioned against the right ventricular apex and outflow 
tract or septum under fluoroscopic guidance. Leads Vi, 
I and III and the intracardiac electrocardiograms were 
recorded on a Siemens Elema Mingograf 7 recorder at 
a paper speed of 25 mm/s. If monomorphic VT was 
induced, a 1Zlead electrocardiogram was recorded 
whenever possible. Stimulation was performed with a 
programmable stimulator (Bloom Associates) using 
stimuli that were twice diastolic threshold and 2 ms in 
duration. 
The details of the stimulation protocol have been de- 
scribed previously.7 In brief, 1 and 2 extrastimuli were 
delivered at the right ventricular apex and outflow tract 
or septum at basic drive cycle lengths of 600 and 400 
ms. If sustained VT was not induced, a third extrastim- 
ulus was added and programmed stimulation was re- 
peated at both sites. The coupling intervals of the extra- 
stimuli were limited to 180 ms because a previous study 
demonstrated that restriction of the coupling intervals 
of the extrastimuli to 180 ms reduces the incidence of 
nonclinical forms of VT without compromising the yield 
of clinically significant VT.7 
The endpoint of the stimulation protocol was either 
the induction of sustained VT or ventricular fibrillation 
or completion of the pacing protocol. Sustained VT was 
defined as VT that lasted >30 seconds in duration or 
required termination because of hemodynamic compro- 
mise. Nonsustained VT was defined as VT that lasted 3 
beats to 30 seconds. Polymorphic VT was defined as VT 
that showed a beat-to-beat variation in QRS morpholo- 
gy. When multiple episodes of nonsustained polymor- 
phic VT were induced at a particular step of the stimu- 
lation protocol, only the longest episode of nonsustained 
VT was noted for analysis. 
Analysis of data: Data are expressed as mean f 
standard deviation. The statistical analyses were per- 
formed using either a chi-square analysis or a Student t 
test. A p value -CO.05 was considered statistically signif- 
icant. 
RESULTS 
seque!kofinducod nonsusbined polymorphii ven- 
tricular taehycardia: Nonsustained polymorphic VT 
was induced in 111 of 206 studies (54%). With continu- 
ation of the pacing protocol, the sequelae of these 111 
studies consisted of induction of sustained monomorphic 
VT in 48 studies (43%), sustained polymorphic VT in 
13 studies (12%) and no sustained VT in the remaining 
50 studies (45%). 
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TABLE I Patient Characteristics 
Sex: M/F loo/30 
Age (yrs. mean f standard deviation) 62f12 
Underlying heart disease 
Coronary artery disease 88 
Valvular heart disease 10 
Dilated cardiomyopathy 7 
Systemic hypertension 5 
None 20 
Indication for electrophysiologic study 
Documented monomorphic ventricular tachycardia 88 
Unexplained syncope 42 
TABLE II Number of Studies in Which 1,2 and 3 Extrastimuli 
Were Used to Induce Sustained Ventricular Tachycardia and 
Nonsustained Polymorphic Ventricular Tachycardia 
No. Sustained Sustained Nonsustained 
of Monomorphic Polymorphic Polymorphic 
Extrastimuli VT vr VT 
1 26 0 9 
2 55 3 38 
3 29 15 64 
VT = ventricular tachycardia. 
In 95 studies, nonsustained polymorphic VT was not 
induced. The outcome of these studies was sustained 
monomorphic VT in 62 studies (65%), sustained poly- 
morphic VT in 5 studies (6%) and no sustained VT in 
the remaining 28 studies (29%). The incidence of these 
outcomes was not significantly different than in studies 
in which nonsustained polymorphic VT was induced. 
lncideince of fBonsu&ined polymorphl wntricular 
tachycardla induc45d before the induction of sustained 
ventricular tachycardia: Sustained monomorphic VT 
was induced in 110 of 206 studies, and 48 of 110 (44%) 
were preceded by the induction of nonsustained poly- 
morphic VT. Sustained polymorphic VT was induced in 
18 of 206 studies, and 13 of 18 (72%) were preceded by 
the induction of nonsustained polymorphic VT. The in- 
cidence of nonsustained polymorphic VT preceding the 
induction of sustained polymorphic VT was signiticant- 
ly greater than the incidence preceding the induction of 
sustained monomorphic VT (p <0.05). 
The number of studies in which single, double and 
triple extrastimuli were used to induce sustained and 
nonsustained VT is listed in Table II. 
Duration and cycle length of induced nonsustained 
polymorphic ventricular taehycardla before the induc- 
tion of sustained ventricular tachycardia: There was no 
correlation between the duration of the induced nonsus- 
tained polymorphic VT and the type of sustained VT 
subsequently induced. The maximal duration of nonsus- 
tained polymorphic VT preceding the induction of sus- 
tained monomorphic VT was 8 f 9 beats, compared to 
14 f 13 beats when preceding the induction of sus- 
tained polymorphic VT (difference not significant). 
The mean cycle length of the induced nonsustained 
polymorphic VT preceding the induction of sustained 
polymorphic VT was shorter than that preceding the 
induction of sustained monomorphic VT (235 f 46 vs 
313 f 70 ms, p <0.05). 
POLVMORPRIC VENTRICULAR TACRYCARDlA 
TABLE Ill Induction of Sustained and Nonsustained VT in 
114 Control and 92 Follow-Up Drug Studies 
Sustained Sustained Nonsustained 
Polymorphic Monomorphic Polymorphic 
v-r VT VT 
Control (%) 13(11) 38 (33) 70 (61) 
Drug follow-up (%) 5 (5) 72 (78) 41(45) 
NS p <O.ool p <0.025 
NS = difference not significant; VT = ventricular tachycardia. 
induction of nonsustained monomorphic ventrkular 
tachycardia before the induction of sustained mono- 
morphic ventrkular tachycardia: In 58 of 206 studies, 
nonsustained monomorphic VT was induced during pro- 
grammed ventricular stimulation. Thirty-nine (67%) 
were followed by the induction of sustained monomor- 
phic VT and only 10 (17%) of these 39 nonsustained 
VTs had a morphology and cycle length similar to the 
sustained VT subsequently induced. The mean duration 
of these nonsustained monomorphic VTs was 16 f 17 
beats (range 3 to 58 beats). 
Cycle length of sustained monomorphii ventriadar 
tachycardia and the induction of nonsustained pdy- 
morphii ventricular tachycardia: The mean cycle 
length of the 48 sustained monomorphic VTs that were 
preceded by the induction of nonsustained episodes of 
polymorphic VT was 303 f 73 ms (range 220 to 490 
ms). The mean cycle length was 358 f 84 ms (range 
220 to 595 ms) for the 62 monomorphic VTs whose 
induction was not preceded by nonsustained polymor- 
phic VT (difference not significant). 
Left ventricular function and the inductiom of sus- 
tained polymorphic ventrkular tachycardia: The left 
ventricular ejection fraction was measured in 76 pa- 
tients who had a total of 127 studies. In patients who 
had a left ventricular ejection fraction >40%, sustained 
polymorphic VT was induced in 1 of 33 studies (3%). In 
patients who had a left ventricular ejection fraction 
<40%, sustained polymorphic VT was induced in 6 of 
94 studies (6%). There was no significant difference in 
the incidence of sustained polymorphic VT between 
these 2 groups of patients. 
Comparison of control and drug 8-s: A compar- 
ison of the control and drug follow-up studies demon- 
strated no significant differences in the incidence of sus- 
tained polymorphic VT (11% of drug follow-up vs 5% of 
control, difference not significant) during programmed 
ventricular stimulation (Table III). There was a higher 
incidence of sustained monomorphic VT (78 vs 33% of 
control, p <O.OOl) and a lower incidence of nonsus- 
tained polymorphic VT (45 vs 61% of control, p <0.05) 
in drug follow-up studies. 
DISCUSSION 
Predictive value of nonsustained polymorphic ven- 
biadar tachycardia during programmed ventrkular 
rtrmuhtion: The results of this study demonstrate that a 
majority (72%) of nonclinical sustained polymorphic 
VTs that are induced by programmed ventricular stim- 
ulation and that require countershock to terminate are 
preceded by the induction of nonsustained polymorphic 
VT. It is therefore possible that the induction of a large 
percentage of sustained nonclinical VTs could be avoid- 
ed if stimulation at a particular step of the stimulation 
protocol was discontinued on induction of nonsustained 
polymorphic VT. However, >40% of clinically impor- 
tant monomorphic VTs were also preceded by the in- 
duction of nonsustained polymorphic VT. Therefore, 
the use of nonsustained polymorphic VT as an endpoint 
for stimulation at a particular step of a programmed 
stimulation protocol would be likely to improve the 
specificity of programmed ventricular stimulation, but 
at the cost of significantly impairing the yield of mono- 
morphic VT. 
The mean duration of the nonsustained polymorphic 
VT that preceded the induction of sustained polymor- 
phic VT and sustained monomorphic VT did not differ 
significantly. Although the mean cycle length of in- 
duced nonsustained polymorphic VT was shorter in 
studies in which sustained polymorphic VT was subse- 
quently induced than in those in which sustained mono- 
morphic VT was subsequently induced, there was much 
overlap in the range of cycle lengths and a critical cycle 
length, below which only the induction of nonclinical 
VT/ventricular fibrillation was likely to occur, could 
not be indentified. Therefore, there are no characteris- 
tics of nonsustained polymorphic VT that are helpful in 
improving its value as a predictor of sustained polymor- 
phic VT. In addition, neither the cycle length of the 
patient’s clinical VT nor the left ventricular ejection 
fraction influences the predictive value of nonsustained 
polymorphic VT. 
Configuration of nonsustained monomurphk ven- 
tricular tachycardia: In this study, <20% of induced 
nonsustained monomorphic VTs were similar to config- 
uration to the sustained monomorphic VTs later in- 
duced. Therefore, nonsustained monomorphic VT in- 
duced during programmed stimulation is not an accu- 
rate predictor of the type of sustained monomorphic VT 
that may be subsequently induced. 
Subjects studied: Our subjects were limited to pa- 
tients who had either a documented history of unimor- 
phic VT or unexplained syncope. Because none of the 
patients studied had a history of sustained polymorphic 
VT requiring countershock, it could be concluded that 
sustained polymorphic VT induced by programmed 
ventricular stimulation in these patients was most likely 
a “nonclinical” arrhythmia. Furthermore, in patients 
with unexplained syncope, the results of previous studies 
have demonstrated that monomorphic VT induced by 
programmed ventricular stimulation is a clinically im- 
portant arrhythmia, whereas polymorphic VT induced 
during programmed ventricular stimulation does not 
have clinical significance.8,9 Therefore, the inclusion of 
only patients who had a documented history of mono- 
morphic VT or unexplained syncope allowed us to reli- 
ably classify induced arrhythmias as clinical or nonclini- 
cal. However, the possibility that polymorphic VT was 
clinically important in some patients cannot be ruled 
out. 
1150 THE AMERICAN JOURNAL OF CARDIOLOGY VOLUME 64 
The results of programmed ventricular stimulation 
are highly dependent on the population of patients un- 
dergoing electrophysiologic testing. It should therefore 
be noted that the sequelae of nonsustained polymorphic 
VT reported in the present study might not be applica- 
ble in groups of patients that differ in composition from 
the subjects of the present study. For example, the yield 
of sustained monomorphic VT would be expected to be 
lower in patients who did not have a history of VT than 
in patients with a documented history of VT. 
Limitations: Forty-live percent of the electrophysio- 
logic studies were performed in the presence of antiar- 
rhythmic therapy. These cases represent a subgroup of 
patients who were more likely to have inducible mono- 
morphic VT when undergoing repeat electrophysiologic 
testing. A potential bias may have been introduced into 
the results, as data from >l study were collected in 
these patients. 
Clinical implications: During programmed ventricu- 
lar stimulation, it is desirable to avoid the induction of 
sustained nonclinical forms of polymorphic VT that re- 
quire cardioversion. Although the induction of nonsus- 
tained polymorphic VT may be a harbinger of sustained 
polymorphic VT if stimulation is continued at the same 
step of the stimulation protocol, the results of this study 
indicate that discontinuation of stimulation may signifi- 
cantly diminish the yield of clinical forms of monomor- 
phic VT, at least in patients who are undergoing elec- 
trophysiologic testing because of a history of mono- 
morphic VT or unexplained syncope. Therefore, pro- 
grammed stimulation should be continued if nonsus- 
tained polymorphic VT is induced. If the coupling inter- 
vals are limited to 180 ms, sustained monomorphic VT 
will be a sequelae of nonsustained polymorphic VT 
much more commonly than will be sustained polymor- 
phic VT. 
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